MSD Merck, Sharp & Dohme AG certified as Top Employer Switzerland in 2021 for the ninth time in a row

Save Print

26. January 2021 08:00 +02:00

As a leading global biopharmaceutical company focused on oncology, vaccines, specialty products and animal health, MSD offers a wide range of career opportunities in an environment where employees feel included.

MSD has been awarded and certified as the Top Employer Switzerland in 2021 for the ninth consecutive time. In 2020, MSD introduced new internal policies to allow a generous gender-neutral parental leave of 16 weeks. In the same year, MSD instituted a new policy giving full flexibility to employees and their managers to determine how much or how often they work remotely. In addition, MSD has put increased emphasis on working in digital ways becoming a more agile organization and more focused on growth and learning.

In order to achieve the Top Employer award, it is crucial to meet the required standards in a stringent assessment process. The Top Employers Institute assessed MSD on the following criteria:

  • Employee Attraction
  • Employee Engagement
  • Employee Development
  • Diversity & Inclusion
  • Ethics & Integrity
  • Digital HR
  • Corporate Culture

About Top Employer

Top Employers Institute is the global authority on recognizing excellence in people practices. The Institute helps accelerate these practices to enrich the world of work. Through the Certification Program, participants can be certified and recognized as an employer of choice. Established more than 25 years ago, Top Employers Institute has certified over 1 600 organizations in 119 countries and regions. These certified companies positively impact the lives of over 6 900 000 employees globally. Crucial factors for gaining the Top Employer Award include above-average ratings under the headings Human Resource Management, Remuneration and Social Security, Career Opportunities, Working Conditions, Education and Training, and Corporate Culture. Only those companies with above-average performance in all these areas are awarded the Top Employer quality label. Further information can be accessed under the following webpage: www.top-employers.com.

About MSD in Switzerland

MSD Switzerland employs over 1000 people working in local, regional and global functions across four sites in the canton of Lucerne and one site in the canton of Zurich. Our business activities are subdivided in the two divisions, Human Health and Animal Health.

MSD Human Health covers a broad range of biopharmaceuticals. Our areas of research and development are focusing on Oncology and Immuno-Oncology as well as Vaccines to prevent diseases for children, young people, and adults against Human Papilloma Virus (HPV), Ebola, Hepatitis, Pneumococcus, Meningococcus, Measles, Rubella, Chickenpox and Herpes Zoster. In addition, MSD is conducting research in the area of infectious diseases to find new therapeutic approaches for antibiotic resistance, HIV/Aids and Hepatitis C. Further research focuses include immunology (auto-immune diseases) as well as cardiometabolic diseases and Diabetes. MSD has a long-lasting legacy in contributing to major public health challenges, such as River Blindness, Ebola and SARS-CoV-2.

MSD Animal Health develops and markets products for the prevention, treatment and control of disease in farm animals and pets. With the most innovative and largest product portfolio for animal health in Switzerland, MSD contributes substantially to animals’ wellbeing.

Our company has one of the largest clinical research programs worldwide. MSD Switzerland conducts 25 clinical trials per year for which the required medicines are manufactured at our research & development site in Schachen. The Schachen site operates since 2018 one of the three MSD forensic laboratories worldwide, investigating in manipulations and counterfeiting of MSD products – an important contribution to patient safety.

At the newly opened Zurich site “The Circle”, our company sets the focus on research & development, data management and the commercialization of our medicines and vaccines. The Zurich hub offers a state-of-the-art work environment where our empowered, culturally diverse and inclusive workforce focuses on scientific excellence to improve people’s health.

MSD Switzerland plays an active role in its community and supports a range of local and regional initiatives as for example MSD for mothers, the health congress “Trendtage Gesundheit Luzern”, and the Swiss City Marathon Lucerne.

Since 2013, MSD Switzerland has been continuously certified as a Top Employer and is pioneering a gender-neutral parental leave program for employees.

For more information www.msd.chwww.de.msd-animal-health.ch

Follow-us on TwitterLinkedIn and YouTube.

About MSD

For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier researchintensive biopharmaceutical company in the world.

For more information, visit https://www.msd.com and connect with us on TwitterLinkedIn and YouTube.

Media department MSD Switzerland
media.switzerland@merck.com | Tel. 058 618 30 30
Jean-Blaise Defago (Policy & Communications Director)

© 2021 MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Luzern. . All rights reserved.

CH-NON-01001, 01/2021